Roth Christine G, Reichard Kaaren K
Am J Blood Res. 2012;2(2):113-8. Epub 2012 Apr 15.
Primary bone marrow presentation of diffuse large B-cell lymphoma (DLBCL) is unusual, and appreciation of the diffuse growth pattern may be difficult in cases with low-level involvement. In particular, subtle sinusoidal and interstitial bone marrow involvement and morphologic overlap of the tumor cells with pronormoblasts may result initially in a missed diagnosis. We describe the clinicopathologic features of 13 cases of morphologically subtle DLBCL involving the bone marrow, which were only identified with the aid of immunohistochemistry. The overwhelming majority of cases (12/13, 92%) presented with cytopenias, and 5 of 7 cases, with available information, had splenomegaly. The morphology of the tumor cells in the aspirate smears overlapped with pronormoblasts (immature erythroid precursors) in 12 of 13 cases. Similarly, in histologic sections, the tumor cells in virtually all cases (12/13) demonstrated round nuclear contours and oblong nucleoli, mimicking pronormoblasts. A CD20 immunohistochemical stain was essential in identifying the neoplastic infiltrate in all cases. The majority of cases (73%, 10/13) showed low-level bone marrow involvement by lymphoma, 10% or less. CD20 immunohistochemistry highlighted individually dispersed and small clusters of large lymphoid cells in a sinusoidal and/or interstitial growth pattern. Most of the cases that were assessed showed a non-germinal center phenotype (CD10-, BCL6-/+, IRF4/MUM1+). There was an aggressive disease course with a median overall survival of 6 months. We would recommend performing a CD20 immunostain in patients who present with unexplained cytopenias and/or splenomegaly. Further investigation is warranted to better describe the features of this unique and aggressive variant of DLBCL.
弥漫性大B细胞淋巴瘤(DLBCL)原发于骨髓的情况并不常见,在低度受累的病例中,识别弥漫性生长模式可能会有困难。特别是,细微的窦状和间质骨髓受累以及肿瘤细胞与原幼红细胞的形态学重叠最初可能导致漏诊。我们描述了13例形态学上细微的累及骨髓的DLBCL的临床病理特征,这些病例仅借助免疫组织化学才得以确诊。绝大多数病例(12/13,92%)表现为血细胞减少,在7例有可用信息的病例中,5例有脾肿大。13例抽吸涂片的肿瘤细胞形态与原幼红细胞(未成熟红细胞前体)重叠的有12例。同样,在组织学切片中,几乎所有病例(12/13)的肿瘤细胞都显示圆形核轮廓和椭圆形核仁,类似原幼红细胞。CD20免疫组织化学染色在所有病例中对于识别肿瘤浸润至关重要。大多数病例(73%,10/13)显示淋巴瘤对骨髓的低度受累,即10%或更低。CD20免疫组织化学突出显示单个分散和小簇状的大淋巴细胞呈窦状和/或间质生长模式。大多数接受评估的病例显示为非生发中心表型(CD10-、BCL6-/+、IRF4/MUM1+)。疾病进程侵袭性强,中位总生存期为6个月。我们建议对出现不明原因血细胞减少和/或脾肿大患者进行CD20免疫染色。有必要进一步研究以更好地描述这种独特且侵袭性强的DLBCL变体的特征。